Delivery Order SPE2DB20D3101-SPE2DB25FRVU7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,346.17 to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of Prilosec DR 10 mg suspension (30 count). This competitively awarded, firm fixed price delivery order is set to be completed by June 9, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs within DLA's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Prilosec DR 10 mg suspension (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $1,874.39 under a firm fixed-price arrangement, with an ultimate completion date of November 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg suspension. The delivery order has a total ceiling value of $14,212.64 and an ultimate completion date of September 26, 2024. The contract is a firm-fixed-price arrangement, and no set-aside designation was used. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Prilosec DR 2.5 mg suspension (30-count units) with a ceiling value of $1,155.57. This competitively awarded, firm fixed-price delivery order is classified as a child contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 11, 2025. No set-aside designation was utilized for this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Prilosec DR 10 mg suspension (30-count), a proton pump inhibitor commonly used to treat gastroesophageal reflux disease and related gastrointestinal conditions. The contract is valued at $1,626.78 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 31, 2025. This award carries no set-aside designation and was competitively...
- The Defense Logistics Agency awarded a $2,097.10 delivery order to AmerisourceBergen Drug Corp for PRILOSEC DR 10 mg suspension (30-count) on November 7, 2025, with completion targeted for November 10, 2025. This firm fixed price, non-set-aside contract represents a direct fulfillment order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at the...
- This federal contract award is for the delivery of Prilosec DR 10 mg suspension medication, with a ceiling value of $15,854.94. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the U.S. Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which does business as Amerisourcebergen. The contract is a delivery order type with a firm fixed price, and has an ultimate...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567908468 - Prilosec DR 10 MG Suspension 30S, a pharmaceutical product. The contract has a ceiling value of $4,039.89 and runs through April 15, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.17 firm fixed-price contract is for the supply of Prilosec DR 10 mg suspension medication, with a completion date of December 24, 2024. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Prilosec DR 10 mg suspension in 30-count packages to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract, valued at $1,599.48, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on May 22, 2024, with a completion date of May 23, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVU7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,633.07 to AmerisourceBergen Drug Corp for Prilosec DR 2.5 mg suspension (30 count) on September 17, 2025, with a completion date of September 18, 2025. This firm fixed price, non-set-aside contract represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and related medical commodities. The company's federal contract portfolio demonstrates consistent capability to fulfill competitive federal medical supply requirements across multiple therapeutic domains and customer bases including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 9/17/25 |